Oregon Administrative Rules
Chapter 855 - BOARD OF PHARMACY
Division 20 - PHARMACIST PRESCRIPTIVE AUTHORITY
Section 855-020-0300 - Protocol Compendium
Universal Citation: OR Admin Rules 855-020-0300
Current through Register Vol. 63, No. 3, March 1, 2024
A Pharmacist may prescribe, via statewide drug therapy management protocol and according to rules outlined in this Division, an FDA-approved drug and device listed in the following compendium:
(1) Continuation of therapy including emergency refills of insulin (v. 06/2023)
(2) Conditions
(a) Cough and cold symptom management
(A) Pseudoephedrine (v. 06/2021);
(B) Benzonatate (v. 06/2021);
(C) Short-acting beta agonists (v.
06/2021);
(D) Intranasal
corticosteroids (v. 06/2021);
(b) Vulvovaginal candidiasis (VVC) (v.
06/2021);
(c) COVID-19 Antigen
Self-Test (v. 12/2021);
(3) Preventative care
(a) Emergency Contraception (v.
06/2021);
(b) Male and female
condoms (v. 06/2021);
(c) Tobacco
Cessation, Nicotine Replacement Therapy (NRT) and Non-NRT (v.
06/2022);
(d) Travel Medications
(v. 06/2023);
(e) HIV Post-exposure
Prophylaxis (PEP) (v. 06/2023);
(f)
HIV Pre-exposure Prophylaxis (PrEP) (v. 06/2023);
(g) Contraception (v. 06/2023); and
(h) Vaccinations:
(A) Standard Protocol for All Vaccines: Cover
Page & Assessment and Treatment Care Pathway (v. 2/2024);
(B) Standard Protocol for All Vaccines:
Managing Adverse Reactions (v. 2/2024);
(C) Cholera (v. 2/2024);
(D) Coronavirus 2019 (v. 2/2024);
(E) Haemophilus Influenza type b (v.
2/2024)
(F) Hepatitis A containing
vaccines (v. 2/2024);
(G) Hepatitis
B containing vaccines (v. 2/2024);
(H) Human Papillomavirus (v.
2/2024);
(I) Influenza -
Inactivated Influenza Vaccines and Recombinant Influenza Vaccines 2023-24 (v.
2/2024);
(J) Influenza - Live
Attenuated Influenza Vaccine 2023-24 (v. 2/2024);
(K) Japanese Encephalitis (v.
2/2024);
(L) Meningococcal
containing vaccines (v. 2/2024);
(M) Measles Mumps & Rubella containing
vaccines (v. 2/2024);
(N)
Pneumococcal (v. 2/2024);
(O) Polio
(v. 2/2024);
(P) Rabies (v.
2/2024);
(Q) Respiratory Syncytial
Virus (v. 2/2024);
(R) Tetanus
Diphtheria containing vaccines (v. 2/2024);
(S) Typhoid (v. 2/2024);
(T) Varicella containing vaccines (v.
2/2024);
(U) Yellow fever (v.
2/2024);
(V) Zoster (v.
2/2024).
Publications referenced are available from the agency.
Statutory/Other Authority: ORS 689.205
Statutes/Other Implemented: ORS 689.645, ORS 689.649, ORS 689.689 & ORS 689.696
Disclaimer: These regulations may not be the most recent version. Oregon may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
